Vrati se na sadržaj

Otolaringologija — hirurgija glave i vrata

Rizici transfuzije i dileme

Anemia during sequential induction chemotherapy and chemoradiation for head and neck cancer: the impact of blood transfusion on treatment outcome. (otvara novi prozor)

Bhide SA, Ahmed M, Rengarajan V, Powell C, Miah A, Newbold K, Nutting CM, Harrington KJ.

Izvor‎: Int J Radiat Oncol Biol Phys 2009;73(2):391-8.

Indeks‎: PubMed 18692326

DOI‎: 10.1016/j.ijrobp.2008.04.052

https://www.ncbi.nlm.nih.gov/pubmed/18692326 (otvara novi prozor)

Does transfusion improve the outcome for HNSCC patients treated with radiotherapy?—results from the randomized DAHANCA 5 and 7 trials. (otvara novi prozor)

Hoff CM, Lassen P, Eriksen JG, Hansen HS, Specht L, Overgaard M, Grau C, Johansen J, Bentzen J, Andersen L, Evensen JF, Overgaard J.

Izvor‎: Acta Oncol 2011;50(7):1006-14.

Indeks‎: PubMed 21790306

DOI‎: 10.3109/0284186X.2011.592650

https://www.ncbi.nlm.nih.gov/pubmed/21790306 (otvara novi prozor)

Transfusion of allogenic leukocyte-depleted packed red blood cells is associated with postoperative morbidity in patients undergoing oral and oropharyngeal cancer surgery. (otvara novi prozor)

Perisanidis C, Dettke M, Papadogeorgakis N, Schoppmann A, Mittlböck M, Kyzas PA, Ewers R, Seemann R.

Izvor‎: Oral Oncol 2012;48(4):372-8.

Indeks‎: PubMed 22182932

DOI‎: 10.1016/j.oraloncology.2011.11.020

https://www.ncbi.nlm.nih.gov/pubmed/22182932 (otvara novi prozor)